Interference 103,781
“described” in 35 U.S.C. § 102, nor rendered any species thereof
obvious to a person having ordinary skill in the art at the
pertinent time.
Claims 41-43 of Fischhoff’s involved application and
Claims 13-14 of Adang involved patent are each limited to a
synthetic gene comprising a specifically identified DNA sequence.
The gene of Claim 41 of Fischhoff’s involved application requires
the specific sequence of 1791 nucleotides identified therein
(Fischhoff’s Priority Brief For Final Hearing (Paper No. 243),
pp. 164-166 (FPB 164-166)). The gene of Claim 42 of Fischhoff’s
involved application requires the specific sequence of 3567
nucleotides identified therein (FPB 166-170). The gene of Claim
43 of Fischhoff’s involved application requires the specific
sequence of 1905 nucleotides identified therein (FPB 166-170).
The gene of Claim 13 of Adang’s involved patent requires “the
DNA sequence presented in Fig. 1 [of the patent], spanning
nucleotides 1 through 1793 (FPB 174). The gene of Claim 14 of
Adang’s involved patent requires “the DNA sequence presented in
Fig. 1 [of the patent], spanning nucleotides 1 through 1833" (FPB
174). We find that the prior art of record does not anticipate
any of the specific genes claimed by Fischhoff or Adang.
On the other hand, the question whether a species of any one
of Claims 41-43 of Fischhoff’s U.S. Application 08/434,105, filed
-37-
Page: Previous 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 Next
Last modified: November 3, 2007